GRAIL vs Thermo Fisher Scientific

Side-by-side comparison of AI visibility scores, market position, and capabilities

Thermo Fisher Scientific leads in AI visibility (79 vs 54)
GRAIL logo

GRAIL

GrowthHealthcare

Liquid Biopsy Cancer Detection

GRAIL develops multi-cancer early detection Galleri test using cell-free DNA methylation to detect signals from 50+ cancer types in a single blood draw; spun off from Illumina in 2024; NHS-Galleri trial enrolling 140,000 participants in the UK.

AI VisibilityBeta
Overall Score
C54
Category Rank
#185 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
60
Perplexity
53
Gemini
57

About

GRAIL is a healthcare company founded in 2016 as an Illumina spinout focused on developing multi-cancer early detection tests using liquid biopsy technology. The company's flagship product Galleri is a blood test that analyzes cell-free DNA methylation patterns to detect cancer signals from over 50 cancer types, many of which lack standard screening tests, enabling detection at early stages when treatment is most effective. GRAIL raised over $3.5B from investors including Amazon and Bristol Myers Squibb and was reacquired by Illumina in 2021 before being spun off again in 2024 as an independent public company following regulatory complications. Galleri has been launched commercially and is being evaluated in large clinical studies including the NHS-Galleri trial in the UK enrolling 140,000 participants. The company represents a transformative approach to oncology that could shift cancer care from reactive treatment toward proactive screening. GRAIL's technology addresses a massive unmet need given that the majority of cancers are diagnosed at late stages when outcomes are poor.

Full profile
Thermo Fisher Scientific logo

Thermo Fisher Scientific

LeaderHealthcare Tech

Enterprise

Thermo Fisher (TMO) reported $42.9B revenue in FY2024, down 1% YoY. World's #1 life sciences company. Serves pharma, biotech, labs globally. ~100,000 employees. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
B79
Category Rank
#23 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
81
Perplexity
79
Gemini
85

About

Thermo Fisher Scientific Inc. is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services to researchers, healthcare organizations, and industrial companies. Headquartered in Waltham, Massachusetts, Thermo Fisher was formed through the 2006 merger of Thermo Electron and Fisher Scientific and has since grown aggressively through acquisitions. The company reported revenues of $42.9B in FY2024, slightly down year-over-year after exceptional COVID-related revenue in 2021–2022.

Full profile

AI Visibility Head-to-Head

54
Overall Score
79
#185
Category Rank
#23
82
AI Consensus
80
stable
Trend
stable
60
ChatGPT
81
53
Perplexity
79
57
Gemini
85
59
Claude
77
55
Grok
77

Key Details

Category
Liquid Biopsy Cancer Detection
Enterprise
Tier
Growth
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only GRAIL
Liquid Biopsy Cancer Detection

Integrations

Only Thermo Fisher Scientific
Thermo Fisher Scientific is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.